Literature DB >> 27908836

Gq and Gs signaling acting in synergy to control GLP-1 secretion.

Maria Hauge1, Jeppe Pio Ekberg1, Maja Storm Engelstoft1, Pascal Timshel2, Andreas N Madsen3, Thue W Schwartz4.   

Abstract

GPR40 is generally known to signal through Gq. However, in transfected cells, certain synthetic agonists can make the receptor signal also through Gs and cAMP (Hauge et al., 2015). Here we find that, in colonic crypt cultures, the GLP-1 secretion induced by such Gq + Gs GPR40 agonists is indeed inhibited by blockers of both Gq and Gs and is eliminated by combining these. This in contrast to Gq-only GPR40 agonists which only are affected by the Gq inhibitor. Importantly, Gq-only GPR40 agonists in combination with low doses of selective synthetic agonists for Gs coupled receptors, e.g. GPR119 and TGR5 provide more than additive GLP-1 secretion both ex vivo and in vivo in mice. It is concluded that under physiological circumstances triglyceride metabolites, i.e. long chain fatty acids and 2-monoacyl glycerol plus bile acids, act synergistically through their respective receptors, GPR40, GPR119 and TGR5 to stimulate GLP-1 secretion robustly by combining Gq and Gs signaling pathways.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  G protein signaling; GLP-1 secretion; GPCR; Incretins; Pharmacological synergy

Mesh:

Substances:

Year:  2016        PMID: 27908836     DOI: 10.1016/j.mce.2016.11.024

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  17 in total

Review 1.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 2.  The current state of GPCR-based drug discovery to treat metabolic disease.

Authors:  Kyle W Sloop; Paul J Emmerson; Michael A Statnick; Francis S Willard
Journal:  Br J Pharmacol       Date:  2018-03-25       Impact factor: 8.739

Review 3.  Targeting lipid GPCRs to treat type 2 diabetes mellitus - progress and challenges.

Authors:  Julien Ghislain; Vincent Poitout
Journal:  Nat Rev Endocrinol       Date:  2021-01-25       Impact factor: 43.330

Review 4.  Non-endocannabinoid N-acylethanolamines and 2-monoacylglycerols in the intestine.

Authors:  Harald S Hansen; Vasiliki Vana
Journal:  Br J Pharmacol       Date:  2018-04-02       Impact factor: 8.739

5.  Ghrelin Does Not Directly Stimulate Secretion of Glucagon-like Peptide-1.

Authors:  Sara Lind Jepsen; Esben Thyssen Vestergaard; Pierre Larraufie; Fiona Mary Gribble; Frank Reimann; Jens Otto Lunde Jørgensen; Jens Juul Holst; Rune Ehrenreich Kuhre
Journal:  J Clin Endocrinol Metab       Date:  2020-01-01       Impact factor: 5.958

6.  Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice.

Authors:  Hyo Shin Yoon; Chung Hwan Cho; Myeong Sik Yun; Sung Jae Jang; Hyun Ju You; Jun-Hyeong Kim; Dohyun Han; Kwang Hyun Cha; Sung Hyun Moon; Kiuk Lee; Yeon-Ji Kim; Sung-Joon Lee; Tae-Wook Nam; GwangPyo Ko
Journal:  Nat Microbiol       Date:  2021-04-05       Impact factor: 17.745

Review 7.  GPR40 Agonist Ameliorate Pathological Neuroinflammation of Alzheimer's Disease via the Modulation of Gut Microbiota and Immune System, a Mini-Review.

Authors:  Jianheng Chen; Qian Li; Jiang Zhu; Zijing Yuan; Tao Wang; Jie Song
Journal:  Neurotox Res       Date:  2021-09-10       Impact factor: 3.911

Review 8.  Glucagon-Like Peptide-1: Actions and Influence on Pancreatic Hormone Function.

Authors:  Ellen M Davis; Darleen A Sandoval
Journal:  Compr Physiol       Date:  2020-03-12       Impact factor: 8.915

9.  L-Cell Differentiation Is Induced by Bile Acids Through GPBAR1 and Paracrine GLP-1 and Serotonin Signaling.

Authors:  Mari Lilith Lund; Giovanni Sorrentino; Kristoffer Lihme Egerod; Chantal Kroone; Brynjulf Mortensen; Filip Krag Knop; Frank Reimann; Fiona M Gribble; Daniel J Drucker; Eelco J P de Koning; Kristina Schoonjans; Fredrik Bäckhed; Thue W Schwartz; Natalia Petersen
Journal:  Diabetes       Date:  2020-02-10       Impact factor: 9.461

Review 10.  What Is an L-Cell and How Do We Study the Secretory Mechanisms of the L-Cell?

Authors:  Rune E Kuhre; Carolyn F Deacon; Jens J Holst; Natalia Petersen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-08       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.